Edinburgh, Scotland (March 21, 2024) - Blackford, the pioneering strategic AI platform and solutions provider, and Radiobotics, the leading MSK AI diagnostics provider, today announced a commercial partnership to bring RBfracture ™ and RBknee ™, to healthcare professionals via the Blackford Platform.
Blackford provides healthcare professionals access to an extensive portfolio of more than 125 AI solutions designed to drive clinical accuracy and efficiency and improve patient outcomes. By integrating Radiobotics’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers more powerful tools to automate fracture detection on X-ray images and analyzing knee X-rays for Osteoarthritis.
"Radiobotics’ solutions to streamline musculoskeletal workflows showcases the transformative power of AI in enhancing patient care and bolstering clinician support" remarked Ben Panter, Founder and CEO of Blackford. "We're excited to integrate these advancements from Radiobotics into our extensive portfolio of AI solutions on the Blackford platform."
RBfracture, a clinical decision support tool, utilizes machine learning to automatically detect fractures on X-ray images in seconds. RBfracture can also detect joint effusions and lipohemarthrosis with great accuracy, highlighting more subtle indications of fractures. RBknee is an automated system for analyzing knee X-rays for Osteoarthritis.
Radiobotics CEO Peter Ulvskjold commented “I am thrilled to announce our collaboration with Blackford, seamlessly integrating Radiobotics' RBfracture and RBknee solutions onto Blackfords’ platform. Together, we're simplifying access to cutting-edge diagnostics, enhancing patient care one partnership at a time.”